NCBiotech News

Durham-based TARGET PharmaSolutions, a clinical data company focused on real-world evidence in disease studies, has launched a new observational study of several inflammatory skin conditions, initially focusing on eczema.

Two Triangle scientists, including NCBiotech staff member Tracey du Laney, Ph.D., and Duke University researcher Kafui Dzirasa, Ph.D., M.D., are among 10 honored today with prestigious fellowships from the American Association for the Advancement of Science.

Sapere Bio is a 6-year-old Research Triangle-based startup using biomarkers to predict biological age so people can stay healthy longer.

New entrants to the biomanufacturing industry recently described for an enthusiastic audience at an NCBiotech event that they're experiencing incredible opportunity, thanks to North Carolina's workforce training system and excellent pool of grateful employers.

IQVIA, established two years ago following the 2016 merger of Research Triangle-based Quintiles and IMS Health, has announced the launch of IQVIA Biotech. This new unit will design clinical and commercial solutions for small biotechnology and biopharmaceutical companies.

According to a report published by Xconomy, startups often look to San Francisco and Silicon Valley for the venture capital they need. But they don’t have to locate there to attract funding. And they might be wiser to consider a lower-cost region like the Raleigh-Durham area instead.

Actus Therapeutics of Chapel Hill has dosed the first patient in a phase 1/2 clinical study of its gene therapy in patients with Pompe disease, a rare genetic disorder that often leads to premature death in children and adults.

Burlington-based healthcare diagnostics company LabCorp has donated $1 million to Alamance Community College (ACC) to support the school’s growing biotechnology and life science curricula.

The North Carolina Biotechnology Center awarded 17 grants and loans totaling nearly $1.4 million to universities, bioscience companies and other organizations in the second quarter of its current fiscal year.

Circassia Pharmaceuticals, a British company with U.S. headquarters in Morrisville, will acquire the exclusive commercialization rights to a life-saving medical device for newborns facing a potentially deadly respiratory condition.

Pfeiffer University broke ground today for a $16 million Center for Health Sciences to be located on Main Street in Albemarle. It will house the school’s new Physician Assistant Studies and Occupational Therapy programs.

TransEnterix, a medical device company located in Research Triangle Park, has received clearance from the U.S. Food and Drug Administration to market its Senhance Ultrasonic System.

Pairwise, a growing agriculture and food company that recently signed a lease for its new site in Durham’s Golden Belt complex downtown, expects to increase its 50 employee headcount by an additional 30 to 40 in 2019.

If your New Year’s resolution is to get out of a low-paying, dead-end job and make a move into a good-paying, fulfilling career in the biopharmaceutical industry, you need to attend the free BPD Spotlight on Education event this Thursday, January 17, from 12:30 to 4 p.m., at the North Carolina Biotechnology Center.

Fifteen STEM students at Immaculata Catholic Middle School in Durham partner with researchers at Precision BioSciences to send a genome editing experiment for the U.S. Naval Laboratory to the International Space Station, to explore whether the technology can help humans, plants and animals adapt to life outside Earth’s atmosphere.